World Pharma News

Bayer

The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Display # 
Title Published Date
Bayer significantly improves earnings 29 July 2015
Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million 10 June 2015
Xarelto® approved in China across three indications in the area of venous and arterial thromboembolism 07 May 2015
Strong start to the year for Bayer 30 April 2015
Bayer aspires to significantly expand Life Science businesses 11 March 2015
Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study 10 February 2015
Bayer operationally strong - strategic focus on Life Science businesses 02 November 2014
Bayer supports World Thrombosis Day as founding global partner 13 October 2014
Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion 01 October 2014
Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies 08 September 2014
Bayer continues positive business development 30 July 2014
Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment 02 June 2014
Bayer HealthCare extends access to clinical trial data 13 May 2014
Bayer: Very successful start to 2014 29 April 2014
Bayer HealthCare to significantly increase production capacity in China 31 March 2014
Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development 18 March 2014
Bayer and Peking University establish new research center for translational research and drug discovery in Beijing 08 January 2014
Bayer plans to acquire Norwegian pharmaceutical company Algeta 19 December 2013
Bayer CEO Marijn Dekkers calls for greater appreciation of innovation 20 November 2013
Bayer continues positive business momentum 03 November 2013

© World Pharma News 2006 - 2015

Top Desktop version